Published in Immunology on July 01, 1987
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev (1998) 1.81
Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol (2005) 1.60
Expression cloning of a human Fc receptor for IgA. J Exp Med (1990) 1.59
Characterization of the IgA receptor from human polymorphonuclear leucocytes. Immunology (1988) 1.39
Whipple's disease: a macrophage disease. Clin Vaccine Immunol (2006) 1.34
Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol (1989) 1.17
A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect Immun (1990) 1.12
Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition. Ann Surg (2000) 1.12
Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology (1993) 1.06
The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology (1990) 1.03
Binding of human IgA1 to rat peritoneal macrophages. Immunology (1988) 0.98
Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol (2005) 0.97
Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect Immun (2007) 0.93
A systematic study of neutrophil degranulation and respiratory burst in vitro by defined immune complexes. Clin Exp Immunol (1995) 0.93
Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a. Clin Exp Immunol (2000) 0.86
Binding, internalization and degradation of soluble aggregates of human secretory IgA by resident rat peritoneal macrophages. Immunology (1988) 0.81
Activation of human monocytes via their sIgA receptors. Immunology (1991) 0.78
Monocyte superoxide secretion triggered by human IgA. Immunology (1989) 0.78
Complement-mediated enhancement of IgA-induced H2O2 release by human polymorphonuclear leucocytes. Immunology (1989) 0.77
IgA-mediated inhibition of human leucocyte function by interference with Fc gamma and C3b receptors. Immunology (1991) 0.76
The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum. Immunology (1991) 0.75
Effects of High-Intensity Endurance Exercise on Epidermal Barriers against Microbial Invasion. J Sports Sci Med (2013) 0.75
Interaction of cells with immune complexes: adherence, release of constituents, and tissue injury. J Exp Med (1971) 2.88
The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J Immunol (1972) 2.80
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol (1978) 2.48
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Lactoperoxidase coupled to polyacrylamide for radio-iodination of proteins to high specific activity. Immunochemistry (1974) 2.25
Secretory component as the receptor for polymeric IgA on rat hepatocytes. J Exp Med (1979) 2.11
Identification of secretory component as an IgA receptor on rat hepatocytes. J Exp Med (1979) 1.89
Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods (1983) 1.85
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Lack of opsonization potential of 11S human secretory A. Proc Soc Exp Biol Med (1973) 1.56
IGA in human bile and liver. J Immunol (1981) 1.50
Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity). Eur J Immunol (1984) 1.48
In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes. Scand J Immunol (1978) 1.47
Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med (1980) 1.44
Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA. Proc Natl Acad Sci U S A (1980) 1.44
IgA-dependent, monocyte-mediated, antibacterial activity. J Exp Med (1980) 1.29
Cytofluorographic analysis of receptors for IgA on human polymorphonuclear cells and monocytes and the correlation of receptor expression with phagocytosis. Mol Immunol (1983) 1.24
Studies on the opsonic activity of human secretory IgA using an in vitro phagocytosis system. J Immunol (1972) 1.16
Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils. Clin Exp Immunol (1986) 1.06
IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol (1984) 1.05
The expression of receptors for IgA on human monocytes and calcitriol-treated HL-60 cells. J Immunol (1985) 1.04
Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte. J Cell Biol (1986) 1.03
Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J Immunol (1972) 1.02
Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol (1982) 1.02
The specificity of receptors for IgA on human peripheral polymorphonuclear cells and monocytes. Cell Immunol (1981) 0.98
Differential binding of IgA proteins of different subclasses and allotypes to Staphylococcal protein A. Z Immunitatsforsch Immunobiol (1977) 0.96
The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes. Clin Exp Immunol (1983) 0.90
Superoxide production from human polymorphonuclear leucocytes stimulated with immunoglobulins of different classes and fragments of IgG bound to polystyrene dishes. Immunology (1978) 0.90
Function of the human liver in IgA homeostasis in plasma. Ann N Y Acad Sci (1983) 0.89
Phagocytic activity of polymorphonuclear leucocytes in patients with IgA nephropathy. Clin Nephrol (1983) 0.88
Circulating immune complexes of IgG, IgA, and IgM classes in various glomerular diseases. Nephron (1982) 0.87
Binding of human IgA fragments to protein A-Sepharose studied with an ELISA method. Scand J Immunol (1985) 0.83
IgA containing material in monocytes from patients with IgA nephropathy. Nephron (1984) 0.80
Opsonic activity of myeloma immunoglobulins (MM-Ig). Am J Hematol (1981) 0.78
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A (1976) 6.65
Early mobilization after myocardial infarction: a controlled study. Br Med J (1973) 5.62
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum (1997) 3.80
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001) 3.49
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum (1996) 2.96
Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet (1995) 2.79
IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol (1992) 2.73
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J (2004) 2.70
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol (1976) 2.64
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42
Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation (1995) 2.36
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum (1995) 2.25
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J (1996) 2.05
Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol (1987) 1.92
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun (1999) 1.87
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods (1993) 1.86
The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol (1989) 1.78
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology (1979) 1.73
Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia (2002) 1.63
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer (2006) 1.61
Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol (2007) 1.60
Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia (2010) 1.60
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. J Immunol Methods (1979) 1.60
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Characteristics of soluble immune complexes prepared from oligovalent DNP conjugates and anti-DNP antibodies. J Immunol Methods (1977) 1.59
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.59
T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol (1992) 1.58
A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int (2006) 1.58
Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med (1999) 1.57
CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy (2014) 1.56
Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci U S A (2001) 1.55
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol (2000) 1.54
Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J Immunol (1981) 1.51
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
C3 requirements for formation of alternative pathway C5 convertase. J Immunol (1976) 1.50
The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol (1997) 1.48
Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol (1998) 1.47
Bone marrow IgA and IgA subclass synthesis in ankylosing spondylitis. J Rheumatol (1992) 1.47
Effect of danaparoid sodium on hard exudates in diabetic retinopathy. Lancet (1997) 1.46
Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. Proc Natl Acad Sci U S A (1988) 1.46
Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood (1993) 1.46
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Why do child mortality rates fall? An analysis of the Nicaraguan experience. Am J Public Health (1991) 1.45
The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol (2000) 1.45
Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med (1980) 1.44
Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum (1992) 1.44
Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol (2001) 1.41
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum (2009) 1.40
Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis (1997) 1.39
Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF). J Immunol (1976) 1.38
Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol (1987) 1.38
Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J (1978) 1.37
The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages. J Immunol (1979) 1.36
Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol (1999) 1.35
Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement. Immunology (1979) 1.35
Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol (1997) 1.34
The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (1985) 1.34
Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes. Kidney Int (1977) 1.32
Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol (2000) 1.32
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation (1984) 1.32
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int (1984) 1.32
Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol (1987) 1.31
Glomerular filtration rate measurement by "single-shot" injection of inulin. Kidney Int (1994) 1.30
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis (1999) 1.30
Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis (1995) 1.29
Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int (1995) 1.29
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost (2006) 1.28
Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol (1981) 1.27
Isolation of stable aggregates of IgG by zonal ultracentrifugation in sucrose gradients containing albumin. Immunol Commun (1979) 1.27
Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol (1995) 1.27
Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. J Immunol (1984) 1.26